Pharmasset, Inc. - Investor Relations

www.Pharmasset.com

July 29, 2010 07:40 PM

Investor Relations

Press Releases

Events & Presentations

Corporate Governance

Financial Information

Search Investor Relations

Investor Relations

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Pharmasset, Inc. 's financial performance into perspective.

Stock Quote

NASDAQ : VRUS
$25.65

0.27

As of Jul 29, 2010 at 4:00 PM ET

Quotes delayed at least 20 minutes. Information provided by eSignal.

Recent Releases

Jul 28, 2010
Pharmasset Initiates Phase 1b Multiple Ascending Dose Clinical Trial of PSI-938 in Patients with Chronic Hepatitis C

Jun 9, 2010
Pharmasset Announces Submission of Abstracts to AASLD Liver Meeting Including an Interim Analysis of Roche's Phase 2b PROPEL Trial of RG7128

View all releases »

Investor Relations Contact

Richard E.T. Smith
Vice President of Investor Relations and Corporate Communications
Office: +1 (609) 613-4181
Email

Site Design by Lakeshore Concepts